F Baert

564 total citations
16 papers, 288 citations indexed

About

F Baert is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, F Baert has authored 16 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 8 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in F Baert's work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (6 papers) and Eosinophilic Esophagitis (3 papers). F Baert is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Microscopic Colitis (6 papers) and Eosinophilic Esophagitis (3 papers). F Baert collaborates with scholars based in Belgium, United States and Netherlands. F Baert's co-authors include Paul Rutgeerts, Séverine Vermeire, Marc Peeters, Robert Vlietinck, Hilde Nevens, Benny Geypens, Yvo Ghoos, D. Claus, Geert Verbeke and Willy Peetermans and has published in prestigious journals such as Gastroenterology, Journal of Crohn s and Colitis and Acta Clinica Belgica.

In The Last Decade

F Baert

14 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F Baert Belgium	7	179	108	98	77	56	16	288
Eric J. Albert Canada	9	104 0.6×	49 0.5×	79 0.8×	117 1.5×	170 3.0×	10	387
Ildikó Földi Hungary	8	186 1.0×	183 1.7×	66 0.7×	68 0.9×	91 1.6×	13	346
Peter Uebel United Kingdom	6	146 0.8×	71 0.7×	79 0.8×	50 0.6×	85 1.5×	8	259
Rémi Duclaux‐Loras France	10	173 1.0×	123 1.1×	87 0.9×	81 1.1×	149 2.7×	32	365
Anton J. Kroesen Germany	11	162 0.9×	127 1.2×	211 2.2×	45 0.6×	11 0.2×	27	361
Dahham Alsoud Belgium	9	239 1.3×	137 1.3×	69 0.7×	48 0.6×	73 1.3×	21	292
Toshifumi Hibi Japan	7	121 0.7×	63 0.6×	53 0.5×	111 1.4×	138 2.5×	10	352
Mike Fiorino United States	4	86 0.5×	44 0.4×	28 0.3×	61 0.8×	193 3.4×	4	282
Ophélie Rouxel France	5	81 0.5×	50 0.5×	48 0.5×	77 1.0×	215 3.8×	7	358
J Manyé Spain	9	106 0.6×	53 0.5×	51 0.5×	122 1.6×	68 1.2×	16	279

Countries citing papers authored by F Baert

Since Specialization

Citations

This map shows the geographic impact of F Baert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Baert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Baert more than expected).

Fields of papers citing papers by F Baert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Baert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Baert. The network helps show where F Baert may publish in the future.

Co-authorship network of co-authors of F Baert

This figure shows the co-authorship network connecting the top 25 collaborators of F Baert. A scholar is included among the top collaborators of F Baert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Baert. F Baert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bossuyt, Julie, et al.. (2025). Switching intravenous to subcutaneous infliximab was safe and successful during 1-year follow up in Ulcerative Colitis and Crohn patients – a Belgian single center experience. Acta Gastro Enterologica Belgica. 88(1). 18–18.

Wauters, Lucas, F Baert, Peter Bossuyt, et al.. (2019). Health literacy, quality of life, work productivity and activity impairment in young adults with Crohn's disease compared to diabetes mellitus patiënts: longterm follow-up from the Belgian Crohn's Disease Registry.. 1 indexed citations

Reinisch, Walter, Remo Panaccione, Peter Bossuyt, et al.. (2018). P274 Factors driving treatment escalation in Crohn’s disease in the CALM trial. Journal of Crohn s and Colitis. 12(supplement_1). S239–S239. 3 indexed citations

Berends, Sophie E., Mark Löwenberg, F Baert, et al.. (2018). DOP046 Higher serum concentrations of vedolizumab are associated with superior endoscopic outcomes in Crohn’s disease: data from the LOVE-CD trial. Journal of Crohn s and Colitis. 12(supplement_1). S063–S063. 8 indexed citations

Vermeire, Séverine, Édouard Louis, Olivier Dewit, et al.. (2017). Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD).. PubMed. 78(1). 26–9. 4 indexed citations

Baert, F, et al.. (2008). ABRIKOSSOFF CELL TUMOR OF THE OESOPHAGUS: A CASE REPORT AND REVIEW OF THE LITERATURE. Acta Clinica Belgica. 63(4). 273–276. 6 indexed citations

Assche, Gert Van, Gilles Paintaud, Geert D’Haens, et al.. (2007). O08 CONCOMITANT IMMUNOSUPPRESSION DOES NOT IMPACT ON THE OUTCOME OF MAINTENANCE INFLIXIMAB THERAPY IN CROHN'S DISEASE: FINAL RESULTS OF THE IMID TRIAL. 1(1). 3–3. 11 indexed citations

Noman, Maja, F Baert, Geert D’Haens, et al.. (2001). HACA formation after infliximab (Remicade™) treatment in Crohn's disease is clearly associated with infusion reactions. Gastroenterology. 120(5). A621–A621. 12 indexed citations

Rutgeerts, Paul & F Baert. (1999). New Strategies In The Management Of Inflammatory Bowel Disease.. Acta Clinica Belgica. 54(5). 274–280. 6 indexed citations

10.

D’Haens, G., Stefaan Colpaert, Marc Peeters, et al.. (1998). The presence and severity of neural inflammation predict severe postoperative recurrence of Crohn's disease. Gastroenterology. 114. A963–A963. 8 indexed citations

11.

Peeters, Marc, Séverine Vermeire, F Baert, et al.. (1998). Confirmation of the importance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease. Gastroenterology. 114. A1059–A1059. 1 indexed citations

12.

Peeters, Marc, Paul Rutgeerts, Karlien Cheyns, et al.. (1997). Presence of pANCA in Crohn's patients with ''UC-like'' clinical, phenotype is related to disease activity. Gastroenterology. 112(4).

13.

Baert, F & P Rutgeerts. (1997). Immunomodulator Therapy of Inflammatory Bowel Disease.. Acta Clinica Belgica. 52(5). 251–257. 3 indexed citations

14.

Peeters, Marc, Benny Geypens, D. Claus, et al.. (1997). Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology. 113(3). 802–807. 209 indexed citations

15.

Baert, F, G D’Haens, Karel Geboes, Nadine Ectors, & Paul Rutgeerts. (1996). TNF-alpha antibody therapy causes a fast and dramatic decrease of histologic colonic inflammation in Crohn's disease but not in ulcerative colitis. Gastroenterology. 4 indexed citations

16.

Baert, F, Willy Peetermans, & Daniël Knockaert. (1994). Yersiniosis: The Clinical Spectrum. Acta Clinica Belgica. 49(2). 76–85. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact